A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 25, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Lymphoma
Interventions
DRUG

plitidepsin

Trial Locations (17)

25123

Spedali Civili di Brescia, Brescia

28033

Centro Oncológico MD Anderson International España, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

28046

Hospital Universitario La Paz, Madrid

33081

Ospedale Clinico Aviano, Aviano

37007

Hospital Universitario de Salamanca, Salamanca

39008

Hospital Universitario Marqués de Valdecilla, Santander

40138

"Instituto di Ematologia Seragnoli", Bologna

41013

Hospital Virgen del Rocío, Seville

50134

Azienda Ospedaliera Universitaria Careggi, Florence

60611

Northwestern University Medical School, Chicago

98109

Fred Hutchinson Cancer Research Center, Seattle

708 52

Faculty Hospital Ostrava, Ostrava

100 34

Fakultni Nemocnice Praha, Prague

08036

Hospital Clínic i Provincial de Barcelona, Barcelona

119 - 129

Hospital Universitari Vall d'Hebron, Barcelona

07010

Hospital Universitari Son Espases, Palma de Mallorca

Sponsors

Lead Sponsor

All Listed Sponsors
lead

PharmaMar

INDUSTRY